SCHEMBL7790657

SCHEMBL7790657

COc1ccc(C(C#N)=NOS(=O)(=O)c2ccccc2C)cc1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 1/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ PDE4B Q07343 6/20 0.39
▸ PDE4A P27815 5/20 0.39
▸ PDE4C Q08493 5/20 0.39
▸ PDE4D Q08499 5/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MAPT P10636 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ ELANE P08246 1/20 0.38
▸ HPGD P15428 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ HCRTR1 O43613 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7790655 1.00 P2RX7 (0.39) P2RX7NPC1RAB9APDE4BPDE4A
SCHEMBL6809982 0.85 POLB (0.38) P2RX7NPC1RAB9APDE4BPDE4A
SCHEMBL7786962 0.85 NPC1 (0.47) NPC1RAB9APDE4BPDE4APDE4C
SCHEMBL7786960 0.85 NPC1 (0.47) NPC1RAB9APDE4BPDE4APDE4C
SCHEMBL27705172 0.83 PLA2G7 (0.40) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL1417509 0.83 PLA2G7 (0.40) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL7789380 0.83 PKM (0.43) NPC1RAB9APDE4BPDE4APDE4C
SCHEMBL7789378 0.83 PKM (0.43) NPC1RAB9APDE4BPDE4APDE4C
SCHEMBL7786974 0.81 ELANE (0.48) PDE4BPDE4APDE4CPDE4DSMN1; SMN2
SCHEMBL7786268 0.81 ELANE (0.48) PDE4BPDE4APDE4CPDE4DSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids CIBA SPEICIALTY CHEMICALS CORP. 2001-11-01 — — US disclosed
US-6017675-A POLYMERIZATION CATALYST CIBA SPECIALTY CHEMIALS CORPORATION (US) 2000-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids QSOX1, HAO2, PAH P2RX7 2358/4885NPC1 3523/4885RAB9A 4084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback